1.04

0.00% 0.00

Pre-market: 1.03 -0.01 -0.96%

Cocrystal Pharma Inc (COCP)

Overview News Price History Financials Discussions Forecast Stock Split

Cocrystal Pharma Inc stock is traded at $1.04, with a volume of 48,249. It is up +0.00% in the last 24 hours and up +0.97% over the past month. Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Previous Close:

$1.04

Open:

$1.03

24h Volume:

48,249

Relative Volume:

0.03

Market Cap:

$14.34M

Revenue:

Net Income/Loss:

$-17.93M

P/E Ratio:

-0.5876

EPS:

-1.77

Net Cash Flow:

$-14.28M

1W Performance:

+2.97%

1M Performance:

+0.97%

6M Performance:

-36.99%

1Y Performance:

-46.39%

1-Day Range:

$1.01

$1.04

1-Week Range:

$1.00

$1.0793

52-Week Range:

$0.90

$3.26

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name

Cocrystal Pharma Inc

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

(786) 459-1831

Address

19805 N. CREEK PARKWAY, BOTHELL, WA

Employee

Twitter

@cocrystalpharma

Next Earnings Date

2024-11-11

Latest SEC Filings

COCP's Discussions on Twitter

Compare COCP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COCP Cocrystal Pharma Inc	1.04	14.34M	0	-17.93M	-14.28M	-1.77
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-20	Initiated	H.C. Wainwright	Buy

Cocrystal Pharma Inc Stock (COCP) Latest News

Dec 04, 2025

Why institutional investors increase stakes in Cocrystal Pharma Inc. (8CC) stockJuly 2025 Review & AI Optimized Trade Strategies - Newser

Dec 04, 2025

Dec 02, 2025

Published on: 2025-12-02 05:48:00 - Newser

Dec 02, 2025

How Cocrystal Pharma Inc. (8CC) stock valuation compares with sectorBond Market & Reliable Price Breakout Signals - Newser

Dec 02, 2025

How Cocrystal Pharma Inc. (8CC) stock behaves under inflation pressureWeekly Market Summary & Weekly High Return Opportunities - Newser

Dec 02, 2025

Is Cocrystal Pharma Inc. (8CC) stock among top earnings playsMarket Risk Analysis & Expert-Curated Trade Recommendations - Newser

Dec 02, 2025

Dec 01, 2025

Cocrystal Pharma, Inc. to Present Clinical Progress Update at NobleCon 21 Conference - Quiver Quantitative

Dec 01, 2025

Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference - GlobeNewswire

Dec 01, 2025

Nov 28, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 By Investing.com - Investing.com Australia

Nov 28, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $3975 - Investing.com

Nov 28, 2025

Nov 25, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 By Investing.com - Investing.com Australia

Nov 25, 2025

COCP insider Phillip Frost updates holdings after 20,000-share trade - Stock Titan

Nov 25, 2025

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812 - Investing.com

Nov 25, 2025

Nov 23, 2025

What analysts say about Cocrystal Pharma Inc 8CC stockSector-Based Investing & High Profit Trading Alerts - earlytimes.in

Nov 23, 2025

Nov 21, 2025

Zacks Small Cap Has Bullish Outlook for COCP FY2025 Earnings - Defense World

Nov 21, 2025

Nov 20, 2025